Congenital adrenal hyperplasia: Difference between revisions
Line 32: | Line 32: | ||
! | ! | ||
|- | |- | ||
| align="center" style="padding: 5px 5px; background: #DCDCDC;" rowspan="2" |21-hydroxylase deficiency | | align="center" style="padding: 5px 5px; background: #DCDCDC;" rowspan="2" |[[21-hydroxylase deficiency]] | ||
|Classic type | |Classic type | ||
| | | | ||
Line 56: | Line 56: | ||
* Normal in non salt wasting | * Normal in non salt wasting | ||
| | | | ||
* CYP21A1 and CYP21A2 gene | |||
|- | |- | ||
|Non-classic type | |Non-classic type | ||
Line 70: | Line 71: | ||
* Normal | * Normal | ||
| | | | ||
* CYP21A1 and CYP21A2 gene | |||
|- | |- | ||
| align="center" style="padding: 5px 5px; background: #DCDCDC;" colspan="2" |17a-Hydroxylase deficiency | | align="center" style="padding: 5px 5px; background: #DCDCDC;" colspan="2" |17a-Hydroxylase deficiency | ||
Line 75: | Line 77: | ||
* Hypertension | * Hypertension | ||
| | | | ||
* Female: normal | |||
* Male: ambiguous | |||
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | | | align="center" style="padding: 5px 5px; background: #F5F5F5;" | | ||
* Increased DOC, corticosterone | * Increased DOC, corticosterone | ||
Line 81: | Line 85: | ||
| | | | ||
* Low | * Low | ||
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |''CYP17A1'' | | align="center" style="padding: 5px 5px; background: #F5F5F5;" | | ||
* ''CYP17A1'' | |||
|- | |- | ||
| align="center" style="padding: 5px 5px; background: #DCDCDC;" colspan="2" |11β-hydroxylase deficiency | | align="center" style="padding: 5px 5px; background: #DCDCDC;" colspan="2" |11β-hydroxylase deficiency | ||
Line 96: | Line 101: | ||
| | | | ||
* Low | * Low | ||
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |''CYP11B1'' | | align="center" style="padding: 5px 5px; background: #F5F5F5;" | | ||
* ''CYP11B1'' | |||
|- | |- | ||
| align="center" style="padding: 5px 5px; background: #DCDCDC;" colspan="2" |3-beta-hydroxysteroid dehydrogenase | | align="center" style="padding: 5px 5px; background: #DCDCDC;" colspan="2" |3-beta-hydroxysteroid dehydrogenase |
Revision as of 15:16, 26 July 2017
This page contains general information about Congenital adrenal hyperplasia. For more information on specific types, please visit the pages on 21-hydroxylase deficiency, 17a-Hydroxylase deficiency, 11β-hydroxylase deficiency, 3-beta-hydroxysteroid dehydrogenase, Cytochrome P450-oxidoreductase (POR) deficiency (ORD), congenital lipoid adrenal hyperplasia, cholesterol side-chain cleavage enzyme deficiency .
Congenital adrenal hyperplasia main page |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Mehrian Jafarizade, M.D [2]
Synonyms and keywords: Congenital adrenal hyperplasia, CAH, Adrenal hyperplasia
Overview
Pathophisiology
Classification
Congenital adrenal hyperplasia is classified into seven types based on the genetic causes that lead to hyperplasia and hormonal imbalance.
Disease | History and symptoms | Laboratory findings | Defective gene | |||
---|---|---|---|---|---|---|
Blood pressure | Genitalia | K levels | ||||
21-hydroxylase deficiency | Classic type |
|
|
Increased:
Decreased:
|
|
|
Non-classic type |
|
|
Increased:
response to ACTH |
|
| |
17a-Hydroxylase deficiency |
|
|
|
|
| |
11β-hydroxylase deficiency |
|
|
|
|
| |
3-beta-hydroxysteroid dehydrogenase | Increased:
Decreased:
|
|
||||
Cytochrome P450-oxidoreductase (POR) deficiency (ORD) | ||||||
Congenital lipoid adrenal hyperplasia | ||||||
Cholesterol side-chain cleavage enzyme deficiency |